Guardant Health, Inc. (GH) › Cash & EquivalentsGuardant Health, Inc. (GH) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $140.54M2019: $143.23M2020: $832.98M2021: $492.20M2022: $141.65M2023: $1.13B2024: $525.54M2025: $378.20M$378.20M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$378.20M-28.0%2024$525.54M-53.6%2023$1.13B+700.3%2022$141.65M-71.2%2021$492.20M-40.9%2020$832.98M+481.6%2019$143.23M+1.9%2018$140.54M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share